Navigation Links
Medivation Announces Fourth Quarter and Year-End 2009 Financial Results Teleconference and Webcast On March 15, 2010
Date:3/12/2010

el small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. In September 2008, Medivation announced a global agreement with Pfizer, Inc to develop and commercialize dimebon (latrepirdine) for the treatment of Alzheimer's and Huntington diseases. With Pfizer, Medivation is conducting a broad dimebon clinical development program that includes several Phase 3 trials assessing the efficacy and safety of dimebon taken alone or in combination with other Alzheimer's medications in patients with mild, moderate and severe Alzheimer's disease. The companies are also conducting a Phase 3 trial of dimebon in Huntington disease. In October 2009, Medivation entered a global agreement with Astellas Pharma Inc. to develop and commercialize MDV3100 for both early- and late-stage prostate cancer. The first Phase 3 clinical trial in the MDV3100 development program, known as the AFFIRM trial, is under way in patients with castration-resistant prostate cancer who have previously been treated with docetaxel-based chemotherapy. For more information, please visit us at www.medivation.com.

SOURCE Medivation, Inc.

Back to top

RELATED LINKS
http://www.medivation.co
'/>"/>

SOURCE Medivation, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Medivation Selected as Founding Member of New NASDAQ(R) NeuroInsights(R) Neurotech Index
2. Medivation Announces Participation in Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
3. Medivation Reports Year-End 2007 Financial Results and Pipeline Progress
4. Medivation Announces Senior Management Promotions
5. Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients
6. Medivation Announces Presentation at the BMO Capital Markets 2008 Focus on Healthcare Conference on August 5
7. Medivation Announces Second Quarter 2008 Teleconference and Webcast on August 11, 2008
8. Medivation Reports Second Quarter 2008 Financial Results and Provides Corporate Update
9. Medivation Announces Participation in Upcoming Conferences
10. Medivation to Host Conference Call at 8:30 a.m. Eastern Time Tomorrow to Discuss Partnering Plans for Dimebon
11. Medivation Receives Corporate Achievement Award From Huntingtons Disease Society of America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Atlanta, GA (PRWEB) May 06, 2015 ... solutions based on the products of cells grown ... on its 105F immunomodulatory treatment candidate for melanoma ... Annual Meeting, taking place May 6-9, 2015 in ... hypoxia-induced multipotent cells produce a soluble material with ...
(Date:5/5/2015)... RURO, Inc., a leading LIMS, RFID and sample ... major content upgrade to its bestselling, Commercial Off-The-Shelf (COTS) ... a significant advancement of FreezerPro® system , ... also simplifying , New FreezerPro® VM ... Download available immediately for free to “Gold” support subscribers ...
(Date:5/5/2015)... N.J. , May 5, 2015 Roka Bioscience, ... on providing advanced testing solutions for the detection of foodborne ... present at the Bank of America Merrill Lynch 2015 Health ... will be held at Encore at the Wynn, ... webcast of the presentation will be available through the investor ...
(Date:5/5/2015)... 2015 Hayden-McNeil is pleased ... custom course materials for smaller courses. This program is ... as 200 students. , “I’m very excited about ... higher education instructors,” said Jeff McCarthy, Hayden-McNeil president. “By ... do our part to make education both more effective ...
Breaking Biology Technology:Novel Immunomodulatory Treatment Induces Apoptosis in Melanoma 2RURO Releases version 7 of FreezerPro® software 2Hayden-McNeil Expands Publishing Program to Service Lower Enrollment Courses 2
... Nov. 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ... Credit Suisse 18th Annual Healthcare Conference on Wednesday, November ... Time). Interested parties may access a live webcast ... http://www.onyx-pharm.com/view.cfm/32/Event-Calendar , It is recommended that listeners ...
... , NORRISTOWN, Pa., Nov. 4 ... premier pharmaceutical solutions company, today announced that it has ... , a contract research organization that specializes in ... business development capabilities. The exclusive partnership leverages the expertise ...
... BOZEN, Italy, November 4 Health Robotics ... i.v.SOFT Workflow Engine at,the American Society of Health-System Pharmacists, ... of the i.v.SOFT Workflow Engine,Health Robotics becomes the first ... automation solution to fill the void of automated process ...
Cached Biology Technology:Emerson Resources Forges Strategic Partnership with Bio Research 2Health Robotics Announces December Launch of the i.v.SOFT(TM) Workflow Engine at ASHP in Las Vegas 2Health Robotics Announces December Launch of the i.v.SOFT(TM) Workflow Engine at ASHP in Las Vegas 3
(Date:4/2/2015)... April 2, 2015 According to ... attributed to somewhat higher than 125 MSEK. This exceeds ... report 2014 that revenues for Q1 2015 would be ... reported for Q4 2014. The operating result for the ... The complete interim report will as previously communicated be ...
(Date:3/31/2015)... , March 31, 2015  Elephant Talk Communications Corp. ... global provider of Software Defined Network Architecture (ET Software ... total revenue of approximately $20.4 million for the year ... $19.5 million for the year ended December 31, 2013. ... the Company had completed its multi-year transition away from ...
(Date:3/24/2015)... Mar. 24, 2015 Research and Markets ... "Global Iris Recognition Market 2015-2019" report to ... Iris Recognition market to grow at a CAGR of ... report covers the present scenario and the growth prospects ... 2015-2019. To calculate the market size, the report considers ...
Breaking Biology News(10 mins):Fingerprint Cards Revises Revenues for Q1 2015 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2
... American Dietetic Association has published an updated position paper ... people with developmental disabilities and special health care needs. ... of technology and the importance of services provided by ... paper, published in the February issue of the ...
... made from tobacco plants has been shown to arrest ... by Arizona State University scientist Qiang Chen and his ... University,s Biodesign Institute and professor in the PolyTechnic Campus, ... demonstrate a plant-derived treatment to successfully combat West Nile ...
... Calif. Biologist Cheryl Hayashi , who studies spider ... to present her work at the prestigious TED Conference ... this year,s TED Conference are Feb. 9-13. Hayashi,s talk ... She is one of about 50 speakers at ...
Cached Biology News:Nutrition services, prevention important in nutrition care for special health needs 2Tobacco plant-made therapeutic thwarts West Nile virus 2Tobacco plant-made therapeutic thwarts West Nile virus 3Tobacco plant-made therapeutic thwarts West Nile virus 4UC Riverside biologist is invited speaker at TED Conference 2
... is a fixative useful for routine procedures. ... is stable and will decalcify small bone ... can be stained successfully with most stains, ... stabilizes red blood cell membranes and cosinophil ...
... is a fixative useful for routine procedures. ... is stable and will decalcify small bone ... can be stained successfully with most stains, ... stabilizes red blood cell membranes and cosinophil ...
Chicken polyclonal antibody to Glutathione-S-Transfrease (GST)...
... microarray informatics platform for microarray data storage, data ... use it forever without paying ongoing license fees. ... has all the analysis tools you need to ... control statistics and normalization, all the way through ...
Biology Products: